The data indicates considerable variation in nervous system disease mortality among countries, with Finland at the highest rate of 147.9 deaths per 100,000 women. While countries like the United States and the United Kingdom also show significant rates, several European nations display relatively lower mortality rates. Year-on-year changes reveal notable increases in Brazil and Colombia, while other countries like Spain and South Africa show declines. The five-year CAGR indicates varying trends across different regions, suggesting differing healthcare challenges.
Future trends to watch include potential increases in chronic neurological conditions due to aging populations, advancements in treatment technologies, and global health initiatives that could affect these mortality rates differently across nations.
Top countries in Nervous System Disease Mortality by Country
| # | 10 Countries | Units (Female Deaths) Per Hundred Thousand Women, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Finland | 147.9 | 2023 | +1.58% | +1.34% | View data |
| 2 | 2 United States | 92 | 2023 | +3.72% | +5.02% | View data |
| 3 | 3 United Kingdom | 65 | 2023 | +4.17% | +3.89% | View data |
| 4 | 4 Brazil | 58.4 | 2023 | +6.57% | +9.92% | View data |
| 5 | 5 Sweden | 51.4 | 2023 | +2.39% | +2.7% | View data |
| 6 | 6 Denmark | 41.2 | 2023 | +1.98% | +1.79% | View data |
| 7 | 7 Australia | 40.6 | 2023 | +1.75% | +2.43% | View data |
| 8 | 8 Netherlands | 39.6 | 2023 | +0.76% | -1.26% | View data |
| 9 | 9 Belgium | 38.5 | 2023 | +0.52% | +0.64% | View data |
| 10 | 10 Spain | 36.8 | 2023 | -2.13% | -1.85% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...